Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
14.5347
29.0321
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Cost of Revenue
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
|
Cost of Revenue
-¥585.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Cost of Revenue
-¥78.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Cost of Revenue
-¥16.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-12%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Cost of Revenue
-¥239.4B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Cost of Revenue
-¥108.6B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
-47%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Cost of Revenue
-¥87.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Glance View
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a CN-based company operating in Food Products industry. The company is headquartered in Dezhou, Shandong and currently employs 607 full-time employees. The company went IPO on 2021-04-21. Shandong Bailong Chuangyuan Bio-Tech Co Ltd is a China-based company mainly engaged in food additives. The firm's main businesses include prebiotic series products, mainly including fructooligosaccharides, isomalt oligosaccharides, galacto-oligosaccharides, xylo-oligosaccharides; dietary fiber series products, mainly including resistant dextrin and polydextrose; other starch sugar (alcohol) products, mainly including maltitol, fructose syrup, and maltose syrup; and healthy sweetener products, mainly for the research and development, production and sales of allulose. The firm's main products are widely used in food, dairy products, infant milk powder, functional beverages, health care products, medicine, animal nutrition and feed industries.
See Also
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Cost of Revenue?
Cost of Revenue
-585.4m
CNY
Based on the financial report for Dec 31, 2023, Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Cost of Revenue amounts to -585.4m CNY.
What is Shandong Bailong Chuangyuan Bio-Tech Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-20%
Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Shandong Bailong Chuangyuan Bio-Tech Co Ltd have been -20% over the past three years , -20% over the past five years .
You don't have any saved screeners yet